The Impact of Hematopoietic Cell Transplantation (HCT) on Survival: An Exploratory Analysis of a Phase 3 Study of CPX-351 Versus 7+3 in Older Patients with Newly Diagnosed, High-Risk/Secondary AML (sAML)
Bibliographic record
Abstract
Introduction CPX-351 (Vyxeos®), a dual-drug liposomal encapsulation of cytarabine (C) and daunorubicin (D) at a synergistic ratio, is approved by the FDA and EMA for adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes. In a phase 3 study, CPX-351 significantly improved median overall survival (OS; 9.56 vs 5.95 mo; HR = 0.69 [95% CI: 0.52-0.90]; 1-sided P = 0.003) and event-free survival (EFS; 2.53 vs 1.31 mo; HR = 0.74 [95% CI: 0.58-0.96]; 2-sided P = 0.021), and produced a higher rate of complete remission (CR) or CR with incomplete platelet or neutrophil recovery (CR+CRi; 47.7% vs 33.3%; 2-sided P = 0.016) vs 7+3 in patients (pts) aged 60-75 y with newly diagnosed high-risk/sAML. The higher CR+CRi rate may contribute to a higher rate of HCT, which is a potentially curative therapy that can impact long-term survival. Objective This exploratory analysis used a time-dependent proportional hazards model to assess the impact of CPX-351 vs 7+3 on survival independent of HCT status. Methods Pts could receive up to 2 induction cycles of CPX-351 (100 units/m 2 [C 100 mg/m 2 + D 44 mg/m 2 ] on Days 1, 3, and 5 [2nd induction: Days 1 and 3]) or 7+3 (C 100 mg/m 2 /d continuously for 7 d [2nd induction: 5 d] + D 60 mg/m 2 on Days 1-3 [2nd induction: Days 1-2]). Pts achieving CR or CRi could receive up to 2 consolidation cycles with CPX-351 (65 units/m 2 [C 65 mg/m 2 + D 29 mg/m 2 ] on Days 1 and 3) or 5+2 (as in 2nd induction). HCT was performed at the physician's discretion. Results Baseline characteristics were balanced between arms. The HCT rate was 34.0% (n = 52) with CPX-351 and 25.0% (n = 39) with 7+3. Median time to HCT was 114.5 d with CPX-351 and 113.0 d with 7+3. Median OS landmarked from the time of HCT was significantly improved with CPX-351 vs 7+3 (not reached vs 10.25 mo; HR = 0.46 [95% CI: 0.24-0.89]). When HCT was treated as a time-dependent covariate, the HRs favored CPX-351 vs 7+3 for OS and EFS (Table), suggesting CPX-351 may be associated with prolonged OS and EFS independent of HCT. The safety profile of CPX-351 was generally consistent with that of 7+3. Early mortality rates with CPX-351 and 7+3, respectively, were 5.9% and 10.6% at Day 30 and 13.7% and 21.2% at Day 60. Conclusions CPX-351 was associated with significantly longer median OS and EFS and higher rates of CR+CRi and HCT vs 7+3 in older pts with newly diagnosed high-risk/sAML. Exploratory analyses suggest CPX-351 prolonged OS and EFS independent of HCT.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.005 | 0.001 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.001 | 0.002 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".